Survac ApS
Survac ApS Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20130115216 | SURVIVIN-DERIVED PEPTIDES AND USES THEREOF - MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-γ-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses thereof. | 05-09-2013 |
20110091489 | SURVIVIN PEPTIDE VACCINE - The present invention relates to a therapeutic vaccine comprising one or more survivin polypeptide fragments. The vaccine can be used for prophylactic, ameliorating and/or curative treatment of e.g. cancer diseases. The invention further relates to methods of combination treatment. | 04-21-2011 |